A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance

Samir Mouhssine; Nawar Maher; Gianluca Gaidano

doi:10.21037/tcr-23-1396

A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance

Samir Mouhssine
, Nawar Maher
, Gianluca Gaidano

Department of Translational Medicine

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	2970-2975
Number of pages	6
Journal	Translational Cancer Research
Volume	12
Issue number	11
DOIs	https://doi.org/10.21037/tcr-23-1396
Publication status	Published - 30 Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Large B cell lymphoma (LBCL)
axicabtagene ciloleucel (axi-cel)
chimeric antigen receptor (CAR)-T cells
effector profiling
simultaneous tumor
treatment resistance

Access to Document

10.21037/tcr-23-1396

Cite this

@article{35226d82521548aab9c65d41ac351a22,

title = "A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance",

keywords = "Large B cell lymphoma (LBCL), axicabtagene ciloleucel (axi-cel), chimeric antigen receptor (CAR)-T cells, effector profiling, simultaneous tumor, treatment resistance",

author = "Samir Mouhssine and Nawar Maher and Gianluca Gaidano",

year = "2023",

month = nov,

day = "30",

doi = "10.21037/tcr-23-1396",

language = "English",

volume = "12",

pages = "2970--2975",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

number = "11",

}

TY - JOUR

T1 - A STEP ahead for CAR-T cell therapy of large B cell lymphoma

T2 - understanding the molecular determinants of resistance

AU - Mouhssine, Samir

AU - Maher, Nawar

AU - Gaidano, Gianluca

PY - 2023/11/30

Y1 - 2023/11/30

KW - Large B cell lymphoma (LBCL)

KW - axicabtagene ciloleucel (axi-cel)

KW - chimeric antigen receptor (CAR)-T cells

KW - effector profiling

KW - simultaneous tumor

KW - treatment resistance

UR - https://www.scopus.com/pages/publications/85179810707

U2 - 10.21037/tcr-23-1396

DO - 10.21037/tcr-23-1396

M3 - Comment/debate

SN - 2218-676X

VL - 12

SP - 2970

EP - 2975

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 11

ER -

A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance

UN SDGs

Keywords

Access to Document

Other files and links

Cite this